An order of 19 crore doses to be supplied from August has been given to Bharat Biotech. It has already been provided with 30 per cent advance money.
To India to achieve its aim of vaccinating all its adults by this December, Bharat Biotech will have to raise its game over the next six months, according to the Union government’s affidavit in the Supreme Court on vaccine availability.
India is counting on Bharat Biotech to supply a total of 48 crore doses of COVAXIN out of the 187 crore. It is needed to vaccinate all 93-94 crore adults in the country.
On June 15, Bharat Biotech shared that it had supplied over four crore doses so far and has some doses in stock with states. As on date, about 3.8 crore COVAXIN jabs have been administered.
Since January till July, an order of 8 crore jabs was placed by the to Bharat Biotech. The company has only delivered half so far out of what it is to supply by end of July. A much bigger order of 19 crore doses to be supplied from August had been placed at Bharat Biotech. It had already been provided 30 percent advance money.
The question of the hour is if Bharat Biotech can increase its supply drastically by nearly nine times its present level. And can it supply nearly 44 crore doses between July and December, when it has struggled to supply four crore doses over last five months.
